TY  - JOUR

T1  - The mTOR pathway as a potential target for the development of therapies against neurological disease.

JO  - Drug News Perspect

PY  - 2007/10/01

AU  - Zemke D

AU  - Azhar S

AU  - Majid A

ED  - 

DO  - DOI: 10.1358/dnp.2007.20.8.1157618

VL  - 20

IS  - 8

SP  - 495

EP  - 499

Y2  - 2024/12/22

ER  -